MedTrace Logo

Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival

NCT00742001 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-08-28

Study results available
· View outcomes & findings →

Summary

Feasibility trial to evaluate recovery and survival of red blood cells (RBCs) from Mirasol-treated whole blood

Conditions

  • Healthy

Interventions

BIOLOGICAL

Mirasol System for Whole Blood.

Treatment of whole blood with the Mirasol system at 3 experimental illumination energies for testing of autologous RBC recovery and survival in healthy subjects

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Terumo BCTbio

    lead INDUSTRY

Principal Investigators

  • Jose Cancelas-Perez, M.D, Ph.D · University of Cincinnati, Hoxworth Blood Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-10
Primary Completion
2008-11-20
Completion
2008-12-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00742001 on ClinicalTrials.gov